Cumberland Pharmaceutical Inc (CPIX)

Form 8-K - Current report

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex PR Newswire NASHVILLE, Tenn., July 1, 2026 $100 million Transaction...

Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference

Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference PR Newswire...

Form 8-K - Current report

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis PR Newswire NASHVILLE, Tenn...

CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA

CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA PR Newswire NASHVILLE, Tenn., May 28, 2026 Commercialization in China...

Form DEFM14A - Definitive proxy statement relating to merger or acquisition

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn., May 5, 2026 Enters into...

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn., April 28, 2026...

Form 8-K - Current report

Cumberland Pharmaceuticals jumps on $100M Apotex transaction

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares surged 80% on Thursday after the company announced a strategic deal with an affiliate of...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report